Background. Normothermic machine perfusion of the liver (NMP-L) is a novel technique that preserves liver grafts under nearphysiological conditions while maintaining their normal metabolic activity. This process requires an adequate oxygen supply, typically delivered by packed red blood cells (RBC). We present the first experience using an acellular hemoglobin-based oxygen carrier (HBOC) Hemopure in a human model of NMP-L. Methods. Five discarded high-risk human livers were perfused with HBOCbased perfusion fluid and matched to 5 RBC-perfused livers. Perfusion parameters, oxygen extraction, metabolic activity, and histological features were compared during 6 hours of NMP-L. The cytotoxicity of Hemopure was also tested on human hepatic primary cell line cultures using an in vitro model of ischemia reperfusion injury. Results. The vascular flow parameters and the perfusate lactate clearance were similar in both groups. The HBOC-perfused livers extracted more oxygen than those perfused with RBCs (O 2 extraction ratio 13.75 vs 9.43 % Â10 5 per gram of tissue, P = 0.001). In vitro exposure to Hemopure did not alter intracellular levels of reactive oxygen species, and there was no increase in apoptosis or necrosis observed in any of the tested cell lines. Histological findings were comparable between groups. There was no evidence of histological damage caused by Hemopure. Conclusions. Hemopure can be used as an alternative oxygen carrier to packed red cells in NMP-L perfusion fluid.
T he rising incidence of chronic liver disease has resulted in increased demand for liver transplantation. 1, 2 This can be met by the progressive utilization of high-risk organs from extended criteria donors. The quality of these livers is already compromised at the time of organ recovery and deteriorates further during static cold storage thereby increasing the risk of early graft dysfunction and/or primary non-function. 3 Machine perfusion is a novel technology that can minimize preservation-associated liver injury, and several groups have already reported promising results from pilot series of patients transplanted with machine perfused grafts. [4] [5] [6] [7] Although the earliest clinical series used hypothermic machine perfusion without oxygenation to mitigate liver damage during preservation, a model requires oxygen. 8 Oxygen requirements during hypothermic or subnormothermic machine perfusion are relatively low due to reduced liver metabolic activity and these can be met by supplying a high fraction of inspired oxygen dissolved in the perfusion fluid.
At 37°C the liver requires adequate oxygen delivery with a dedicated oxygen carrier to enable and support full liver metabolic activity. 10 To date, all clinical transplant series using organs preserved by normothermic machine perfusion of the liver (NMP-L) have used red blood cells (RBC) as oxygen carriers. 5, 6, [11] [12] [13] [14] Although blood-based perfusion fluid is physiological, it has also several potential disadvantages including immune-mediated phenomena, blood-borne infectious transmission, RBC hemolysis, use of a precious resource and logistical difficulties associated with using cross-matched blood. [15] [16] [17] [18] These reasons pose problems too for the use of third-party blood in clinical practice. Recently, in a bid to overcome these issues, a team from The University of Bristol and NHS Blood and Transplant presented a feasible approach to the manufacture of red cells for clinical use from in vitro culture. 19 Acellular oxygen carriers have been developed and tested as an alternative to packed red cell transfusions. 20, 21 Hemopure (hemoglobin glutamer-250 [bovine]; hemoglobin-based oxygen carrier (HBOC)-201, Hemoglobin Oxygen Therapeutics LLC, Cambridge, MA) is a polymerized bovine HBOC of low immunogenicity and an oxygen carrying capacity similar to that of human hemoglobin at normothermic temperatures. 21 , 22 Fontes et al 23 recently reported successful sub-NMP-L using Hemopure in combination with a colloid in a porcine liver transplant model.
Here we present the first experience using an acellular HBOC-based perfusion fluid in human livers during normothermic machine perfusion.
MATERIALS AND METHODS

Study Design
The study was performed on 10 rejected donor livers offered to our center for research between August 2014 and July 2016. Five organs were perfused with a Hemopurebased perfusion fluid (HBOC group) and 5 with a packed RBC-based fluid (RBC group) and underwent 6 hours of NMP-L. The HBOC and RBC livers were matched according to type of organ donation (donor after brain death or circulatory death) and function based on the unit's developed viability testing protocol. All 3 viable RBC livers were successfully transplanted. 6 
Source of Discarded Human Livers and Liver Tissues
The discarded livers included in the study were initially offered, accepted, and procured (using nationally agreed surgical protocols 24 ) with the intention to use them for clinical transplantation. The livers were declined by all UK transplant centers and offered for research by the National Health Service Blood and Transplant (NHSBT) coordinating office. Ethical approval for the study was granted by the LondonSurrey Borders National Research Ethics Service committee as well as Loco-Regional and NHSBT Ethics Committees (reference 13/LO/1928 and 06/Q702/61). The tissue used for the cellular isolation and in vitro toxicity experiments was obtained from fully consenting adult patients undergoing hepatic explant or resection at the University Hospital Birmingham.
NMP-L
Normothermic machine perfusion was performed using the Liver Assist device (Organ Assist, Groningen, The Netherlands) which perfuses both hepatic arterial and portal venous systems as described previously. 6 The perfusion pressure was initially set at 30 mm Hg in the arterial and 8 mm Hg in the portal circuit respectively, aiming to achieve arterial flow greater than 150 mL/min and portal flow more than 500 mL/min. The resistances differed between livers, and if required, the pressures were gradually increased up to 50 and 12 mm Hg for artery and portal vein, respectively, to achieve the target flows. Oxygen was supplied to maintain an approximate target arterial pO 2 of 20 kPa (mean hepatic artery pO 2 throughout perfusion 22.23 kPA). The temperature was initially set to 25°C and increased incrementally to 37°C within 30 minutes. The liver preparation was analogous to clinical transplantation. Vessels were prepared to enable cannulation with 20 French, Medos cannulae and a transparent plastic tube was inserted into the bile duct, and the cystic duct was ligated. Livers were then flushed with 2 L of 10% dextrose solution at room temperature to remove any excess extracellular potassium, as per our unit's standard protocol for clinical transplantation, before being connected to the device.
Hemopure
This bovine hemoglobin product is processed to eliminate RBC constituents, bacterial endotoxins, viruses, and the prions responsible for variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. The result is a sterile glutaraldehyde-polymerized bovine hemoglobin (30-35 g Hb per 250 mL) which is added to a modified Ringer lactate solution. Hemopure has an average molecular weight of 250 kDa and can be stored at 2°C to 30°C for up to 3 years. 25 The oxygen affinity of human hemoglobin is dependent on 2,3-biphosphoglycerate, which is present in RBCs. The oxygen affinity of Hemopure, however, is modulated by chloride ion concentration. As such, its oxygen dissociation curve is shifted to the right compared with that of corpuscular hemoglobin and hence will release oxygen more readily into the tissues. It has a P50 (oxygen pressure at which 50% of oxygen-binding sites are saturated) of 40 mm Hg (±6 mm Hg), compared with 27 mm Hg for human hemoglobin.
Perfusion Fluid Constitution
We used a perfusion fluid developed by our team for resuscitation of discarded livers. 26 This consisted of 3 units of groupspecific Rhesus-negative donor packed RBCs obtained from the local blood bank, or an equivalent volume of Hemopure. The remaining perfusion fluid constituents are detailed in Table 1 and the biochemical starting compositions of the fluids are shown in Table 2 . Details of exact fluid constituents can be found in the Appendix as supplementary material (SDC, http://links.lww.com/TP/B451.
Assessment of Liver Physiology and Sample Collection Protocol
The macroscopic appearance of the liver was assessed throughout the course of NMP-L. The perfusion and sampling protocol included recording of arterial and venous circuit flow rates (mL/min for hepatic artery, L/min for portal vein), pressure (mm Hg), resistance (mm Hg·min/L), and temperature (°C) at 30-minute intervals. At the same intervals, we sampled arterial and hepatic venous perfusion fluid that was immediately assessed using a Cobas b 221 point of care system (Roche Diagnostics, USA). The oxygen extraction ratio was calculated using the following equation; O 2 extraction ratio (ER)/g tissue = [(SaO 2 − SvO 2 )/SaO 2 ]/liver mass (g). Bile was collected at hourly intervals and weighed at the end of the procedure. Mean or median perfusion parameter values were calculated using results recorded at 30-minute intervals. Determination of organ viability was as per our criteria for organ viability used in a pilot series of transplantation using discarded donor livers 6 (see supplementary material for more information, SDC, http://links.lww.com/TP/B451).
Histological Assessment
Liver biopsies were taken before the start of NMP-L and after 6 hours of perfusion. Biopsies were fixed in formalin, embedded in paraffin and sections cut at 4 μm then stained with hematoxylin and eosin (H&E) and periodic-acid Schiff (PAS). Biopsies were assessed for preexisting acute or chronic liver injury. The percentages of large and small droplet macrovesicular steatosis, coagulative necrosis, subtle zone 3 changes of detachment of hepatocyte plates from the sinusoidal endothelium and glycogen depletion was determined. 27 Histological assessment was conducted by an independent experienced liver transplant pathologist without prior knowledge of the liver perfusion designated category.
Perfusate and Tissue Analysis
Perfusates and tissues were snap-frozen at different time points for subsequent analyses. This included analysis of tissue adenosine triphosphate (ATP) content, and analysis of the perfusate for levels of transaminases and 8-hydroxy-2′-deoxyguanosine (8-OH-dG)-an established marker of oxidative stress. The protocol for ATP extraction can be seen in the Appendix as online supplementary material (SDC, http://links.lww.com/TP/B451). All perfusates underwent hemoglobin depletion using Hemoglobind (BioTech Support Group LLC, Monmouth Junction, NJ) as per the manufacturer's instructions, except using a 1:8 ratio to ensure removal of all free hemoglobin. Perfusate levels of 8-OHdG were quantified using a competitive ELISA (Abcam) as per the manufacturer's protocol.
Primary Human Hepatocyte, Human Sinusoidal Endothelial Cell, and Human Biliary Epithelial Cell Isolation
The isolation of primary human hepatocytes, 28 sinusoidal endothelial cells, 29 and biliary endothelial cells 30 has been previously described, the detailed protocols for which are supplied in the Appendix as online supplementary material (SDC, http://links.lww.com/TP/B451).
In Vitro Model of Ischemia Reperfusion Injury
Cells were incubated in the standard media for each cell type or 50:50 mix of standard media with Hemopure (the same concentration as is present in the perfusion fluid). In experiments, human hepatocytes, human sinusoidal endothelial cells (HSEC) and biliary epithelial cells (BEC) were grown for 3 days in standard media, in 6-well plates coated with rat type 1 collagen, at 37°C in 5% CO 2 . We used a model of warm in vitro ischemia reperfusion injury (IRI) that we have described previously, 31 the details of which are within the supplementary material (SDC, http://links.lww.com/TP/B451).
Assessment of Reactive Oxygen Species Production, Apoptosis, and Necrosis
Reactive oxygen species (ROS) production, apoptosis, and necrosis were determined using a 3-color assay as previously described. 32 For further details and precise flow cytometry protocol please refer to the supplementary material (SDC, http://links.lww.com/TP/B451) and our previous publications. 31, 33, 34 All data are expressed as median fluorescence intensity. Taken together, these 3 markers give a comprehensive assessment of the magnitude of IRI in primary human liver cells.
Statistical Analysis
Categorical data are presented as numbers and percentage and were compared with Fischer exact test. Continuous variables are expressed as mean and standard deviation or Donor demographic, liver characteristics, and machine perfusion data median with range (where appropriate) and were compared using t tests or 2-tailed Mann-Whitney U test. A P value less than 0.05 was deemed significant and was rounded to 3 decimal places for the presentation of results. All statistical analyses were performed using Prism 6 for Mac software (Graphpad Software Inc, La Jolla, CA).
RESULTS
Donor Characteristics
Most livers (8 of 10) were from donors after circulatory death (DCD). The median (range) donor age was 48 (25- 35 The most common reason for the organ being declined for transplantation was prolonged donor warm ischemic time in combination with suboptimal macroscopic liver appearance. The detailed characteristics are provided in Table 3 , and examples of these livers in Figure 1 .
Machine Perfusion Parameters
The HBOC group livers established global perfusion rapidly and the liver surface appeared homogenous within the first 5 minutes. This observation was reflected in the lower initial hepatic arterial resistance and pressure required to achieve the target flow rates within the initial Figure 2 ). By the time the target perfusate temperature of 37°C was reached and stabilized, the appearance of the RBC livers improved and both groups demonstrated similar perfusion parameters throughout the remaining perfusion course. The detail is shown in Figure 2 and Tables 3 and 4 .
Liver Viability and Oxygen Consumption HBOC perfusion fluid provided sufficient oxygen delivery for livers to perform metabolic functions that indicate their viability (Figure 2 ). Active liver metabolism was also confirmed by the progressive storage of glycogen in hepatocytes (Figure 3 ). There was progressive regeneration of ATP stores over the course of the perfusion, and there were no differences between the RBC and HBOC groups (Table 4 and Figure 2, panel H) . There was an increase in perfusate levels of 8-OH-dG, an established marker of oxidative stress, although this appeared to plateau after the first 2 hours of perfusion and again, there were no differences between the RBC and HBOC perfused groups (Figure 2 , panel G). There was a significantly higher oxygen extraction observed in the HBOC group compared with the RBC group, and this difference was apparent throughout the course of the perfusion (Figure 2, panel F) .
Histological Assessment
The viable livers in the Hemopure group had a similar histological appearance to those perfused with packed RBC (not shown) with the majority of hepatocytes showing normal morphology with an intact hepatocyte plate/sinusoidal lining (Figure 3a .A-D). After perfusion with Hemopure, the vasculature appeared to contain a pink-staining solution (3a.E) which was not present after RBC-based perfusions and which appeared to be flushed out effectively with 2 L 10% dextrose at the end of the perfusion process (Figure 3a.F) . Extrahepatic bile ducts perfused with Hemopure maintained normal morphology (Figure 3a .C) with a largely intact surface epithelium, viable epithelial lining of the deep peribiliary glands and no loss of stromal nuclei, arterial FIGURE 1. Macroscopic liver appearance. Hemopure perfused liver 5 before (A) and 1 minute after (B) commencing the perfusion. This liver was poorly perfused in situ and on the back table during the retrieval process, however performed very well and a homogenous perfusion was achieved almost immediately, helped by the low viscosity of the fluid. Hemopure perfused liver 1 before (C) and 5 minutes after (D) commencing the perfusion. Despite the severely steatotic nature of the graft, a homogenous perfusion was still achieved shortly after almost 7 hours of cold storage. FIGURE 2. Perfusion parameters. Hepatic artery flow rates (A) and portal vein flow rates (B) in Hemopure and RBC perfused livers. Hepatic artery pressure (C) and resistance (D) showed slight differences in the pressure settings used, however the resistances over the course of the perfusion were similar. The resistance in cold livers were observably lower (within first 30 minutes as liver warmed) in the Hemopure group, likely due to the low viscosity of the fluid. There were no differences in lactate metabolism (E), 8-OH-2-dG production (G) or ATP replenishment (H). O 2 ER (F) was increased in livers perfused with Hemopure. Figure 3b ) or maintained high glycogen stores during perfusion, whereas those which were deemed nonviable failed to restore glycogen reserves (Table 5) . PAS stain was unaffected by the presence of Hemopure. Importantly, there was no histological evidence of damage caused by Hemopure infusion and livers that were viable according to our criteria, had similar histological features in both RBC and HBOCinfused groups. Although we do not use the scoring system at our center, when we compared the 2 groups histologically using our own system or Suzuki's criteria for IRI, 36 there were no observable differences.
In Vitro Cytotoxicity Testing of Hemopure HSEC and BEC did not increase intracellular ROS production during in vitro IRI when cultured in standard media (Figure 4a ). Human hepatocytes demonstrated increased ROS accumulation when exposed to hypoxia that was accentuated during hypoxia reoxygenation (H-R) as we have previously demonstrated. 31 When human hepatocytes, HSEC or BEC, were cultured in Hemopure-containing media, there was no significant increase in intracellular ROS production during normoxia, hypoxia or H-R. These results demonstrate that Hemopure does not increase ROS accumulation in isolated primary liver cells during in vitro IRI.
Our previous work has shown that increases in intracellular ROS increase cell death in parenchymal liver cells primarily via apoptosis but also necrosis. 31 As Figure 4b demonstrates, when human hepatocytes, HSEC or BEC, were cultured in Hemopure during normoxia, hypoxia or H-R there was no increase in apoptosis relative to cells cultured in standard media. There was no increase in necrosis in human hepatocytes, HSEC or BEC during in vitro IRI when cultured with Hemopure (data not shown). Hemopure therefore shows no increase in cytotoxicity in primary human liver cells during IRI.
DISCUSSION
Organ machine perfusion is becoming an increasingly attractive preservation method since experimental studies have demonstrated it mitigate IRI and potentially improve allograft function. 8 In particular, data from early clinical transplant series using normothermic machine perfused grafts show promising results and provide a potential means of overcoming the critical shortage of donor organs. 6, 11, 12, 37, 38 Regardless of perfusion temperature, it is generally accepted that oxygenation of the perfusate is advantageous. 4 Here we show for the first time that Hemopure, an acellular oxygen carrier, has the potential to replace packed red cells as the oxygen carrier of choice in a human NMP-L model. This study was primarily designed to assess the feasibility of Hemopure to replace RBC in a model of viability testing using NMP-L. This is not a model of true reperfusion given that we do not use whole blood and there is no immune cell population (other than resident immune cells) in the perfusate, however, including a subsequent reperfusion step to simulate a clinical transplantation would not have added any additional information to the chosen study endpoint.
In the present experiments, we observed increased oxygen consumption in the HBOC liver group. We believe this to be a result of the physiological and rheological properties of Hemopure. As previously described, the oxygen dissociation curve of Hemopure lies to the right of corpuscular hemoglobin (with a p50 of 40 mm Hg) and therefore gives up oxygen to tissues more readily. 38, 39 This difference was more pronounced at the initial phase of the perfusion, before the liver core and the perfusate temperature reaching 37°C, during which Hb-O 2 affinity would normally be increased, giving oxygen to tissues less freely. Across all temperatures therefore, Hemopure will give up more oxygen to tissues than corpuscular hemoglobin. Additional properties such as a molecular diameter approximately 1/1000th the diameter of a red-blood cell and the fact Hemopure is a less viscous fluid, result in a more homogenous perfusion 39 and facilitate the diffusive transport of oxygen in the microcirculation improving tissue oxygenation. Low-viscosity preservation fluids may protect against the development of posttransplant biliary complications however this aspect of NMP-L requires further research. [40] [41] [42] The apparent advantage of a lower O 2 affinity did not translate to a reduction in intracellular ROS when using Hemopure in the IRI model in vitro and the reasons for this remain the focus of ongoing research in our laboratory. Crucially, Hemopure did not induce cell death in primary human liver cells during IRI. One of the acknowledged protective mechanisms of NMP-L is attenuation of IRI because the organ replenishes energy stores within an environment free from recipient immune-mediated injury, thereby minimizing ROS accumulation at true reperfusion-a central trigger of allograft necroapoptosis observed after transplantation. 31 Porcine HBOC's have been shown to exhibit antioxidant activity in vitro and significantly inhibit hydrogen peroxidemediated endothelial cell damage and apoptosis. 43 They have also been shown to have a protective effect on focal cerebral IRI in an animal model. 44 There is mounting evidence that circulating resident leukocytes, or those few that may be present in blood products, can activate proinflammatory signaling pathways that accentuate organ damage. 45 Although a leukocyte filter decreases the amount of circulating leukocytes, cells trapped in the filter can still potentially trigger proinflammatory cascades that activate ROS, damage-associated molecular pattern molecules and cytokine production, impacting upon organ quality. [45] [46] [47] Damage-associated molecular pattern molecule filters are starting to be trialed in some perfusion research settings. Third-party blood can also sensitize the organ recipient and although its significance in preventing liver damage will require further research, replacing RBC with HBOC has would avoid these phenomena. 48 Some models do not require the use of third-party blood products. At present, for normothermic perfusion of the heart, the organ recovery team obtains whole donor blood at the time of organ procurement. 11 However, this approach is not feasible for all potentially recovered donor organs as the blood volume to prime the perfusion devices would be more than the circulatory volume of the donor. The logistics of retrieving donor blood is also unfavorable because it causes severe hypotension and leads to a delay in cross clamping the aorta. Although third-party blood provides good results for NMP-L, there are several reasons why finding alternatives may be an important development for the clinical adoption of machine perfusion in the future. The obvious reason is to avoid any unnecessary blood usage-a scarce resource and vital for major surgical procedures or other therapeutic interventions. Complying with ethical and legislative regulations, acquiring approval for third-party blood to be used in NMP-L research is a lengthy process. Using an acellular oxygen carrier would avoid this and overcome other challenges that are associated with the use of blood products such as traceability. Additionally, HBOCs do not require crossmatching and have a long shelf-life at room temperature. In our experience, this prevented delays and minimized the cold ischemic time which is a key factor when attempting to use extended criteria donor livers.
Whereas our research team has focused on viability testing and maximizing organ utilization in a model of NMP-L, others have pursued subnormothermic 23 or hypothermic in a bid to improve the long-term results in organs from DCD donors. 4, 9 The optimal temperature for liver perfusion remains a matter of continuing discussion and an area of intensive research. [49] [50] [51] Hemopure can deliver oxygen within the wide range of the conventionally used machine perfusion temperatures (10-37°C), currently being trialed in clinical and research settings. 23, 50 NMP-L can also be used to improve logistics through significantly extending the organ preservation time. 5 Hemolysis caused by sheer stress from the device pump and circuit tubing decreases the perfusate oxygen carrying capacity over time and is currently one of the main limiting factors for further extension of organ preservation times. 52 The hemolysed RBC debris, although eventually cleared by the liver, may adversely disrupt the hepatic microcirculation, particularly in the peribiliary vascular plexus during the NMP-L procedure. A purified acellular fluid theoretically avoids these limitations. The half-life of Hemopure is 16 hours and recurring anemia in the clinical setting is usually noted 24 hours after administration. We have not observed any degradation of the product however its stability beyond 6 hours of perfusion is yet to be tested. 53 One of the constraints for wider and faster implementation of the NMP technology into the organ FIGURE 4. Toxicity testing. The effects of Hemopure on ROS production and apoptosis in human hepatocytes, human HSEC, and human BEC. A, Isolated human hepatocytes, HSEC and BEC were exposed to the in vitro model of IRI in the presence and absence of Hemopure and the effect upon intracellular ROS accumulation was assessed using 2′,7′-dichlorofluorescin. Data are expressed as MFI and calculated as described in Materials and Methods section (n = 3-6). B, The bottom panel shows representative flow cytometry plots demonstrating the effects of Hemopure on apoptosis in human hepatocytes, HSEC and BEC during hypoxia. Similar plots were obtained during normoxia and H-R (data not shown). MFI, medium fluorescence intensity.
preservation pathway is its high cost. Hemopure costs more per unit than RBCs; however, this cost could be offset by the numerous advantages its use offers. 54 There has been a longstanding interest in developing an efficient and safe alternative to donor blood. Several products have been tested mainly in the preclinical setting with promising results although they have not been adopted into routine clinical practice. 20, 55 Despite negative reports from a meta-analysis examining the use of 5 different HBOC products, Hemopure has demonstrated clinical efficacy in trials investigating its use in general, urological, orthopedic, vascular and cardiac surgery, though it demonstrated some side effects, most commonly hypertension and bradycardia. 21, [56] [57] [58] [59] Liver machine perfusion with Hemopure ex situ avoids the potential complexities of systemic in vivo interactions and their potential side effects. Histological assessment also showed that flushing the liver at the end of NMP-L effectively removes Hemopure from the liver, so only a very small volume (if any) would reach the recipient circulation.
The main limitation of our study is being unable to assess the effect of true reperfusion during transplantation as the livers were not transplanted. We also chose not to simulate the reperfusion effect by NMP-L with whole blood containing immune cell populations. This model, however, provided reassurance that Hemopure does not cause any apparent histological damage, and it is able to deliver enough oxygen to fully support human liver metabolism at normothermic condition. Such confirmation was necessary before evaluating Hemopure in a clinical transplant setting.
In conclusion, this study suggests that Hemopure-based perfusion fluid is a feasible alternative to the blood-based solution currently used for NMP-L. Hemopure may be logistically, rheologically, and immunologically superior to packed red cells when used in a normothermic perfusion model. Our findings warrant further HBOC-based machine perfusion fluid testing in a pilot clinical trial.
